Navigation Links
Central in Medical Technology
... unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and ... the Benelux countries, and Poland for Eastern and central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. ...
... the treatment of certain eye diseases, to include central Retinal Vein Occlusion (CRVO). The companies plan ... this year. CRVO is caused by obstruction of the central retinal vein that that leads to a back up of ... from CRVO. CRVO is caused by obstruction of the central retinal vein that leads to a back up of blood and ...
... to help prevent infections related to the use of central line catheters. central venous catheters or central line catheters are tubes placed into a large vein ...
... The most common adverse events were related to central venous access, such as catheterization and catheter removal, central line infection and pyrexia. The study was ... including countries in Asia and South and central America, where the product is approved based on ...
... focused on the treatment of obesity and other central nervous system-related disorders, today ... focused on the treatment of obesity and other central nervous system-related disorders. The Company's ... to act on a specific group of neurons in the central nervous system with the goal of achieving ...
... (PFS) assessed via a blinded, independent central review and defined as the amount of time between ... groups (2% vs. 0% of responders). However, in a central review among patients evaluable for best ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... by continuously inhibiting the mTOR protein, a central regulator of tumor cell division and blood vessel ... RAD001 inhibits mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... (PFS) assessed via a blinded, independent central review and defined as the amount of time between ... groups (1% vs. 0% of responders). However, in a central review among patients evaluable for ... RAD001 inhibits mTOR, a protein that acts as a central regulator of tumor cell division, ...
... Hospital, a major healthcare facility in West central Minnesota, today announced results from a ... range from complete automation systems for the central pharmacy to nursing unit and bedside dispensing ... facility that encompasses 14 counties in west central Minnesota and is licensed for 136 beds to provide ...
... reaches the brain and S1P-Rs are present on central nervous system (CNS) tissue, so FTY720 may have a ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ... 8425 Isabella Zinck +41 61 324 7188 central phone no: +41 61 324 7944 Fax no: ...
... disease) breathe more easily. central DuPage Hospital is the only site for the EASE ... and principal investigator of the study at the central DuPage Hospital site. "Emphysema, ... visit http://www.theEASEtrial.com . About central DuPage Hospital ...
... to expand our pipeline of product candidates in central nervous system disorders," said Paul E. Freiman, ... Technologies and Buck focused on central nervous system conditions. "With these ... on developing novel, first-in-class agents for central nervous system conditions and other serious ...
... treatment by inhibiting the mTOR protein, a central regulator of tumor cell division and blood vessel ... inhibits mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism ... metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal ...
... cord that often leads to stroke or death. Primary central nervous system vasculitis (PCNSV) can best be ... a combined diagnostic approach is needed. Primary central nervous system vasculitis is difficult to ... of the Mayo Clinic Research Primary central nervous system vasculitis has two traits that ...
... disease is a progressive disorder of the central nervous system. The patients -- roughly four ... a lack of dopamine, a messenger substance in the central nervous system, which is responsible for the ... and biotechnology products in the fields of central nervous system disorders, ...
... (GI) transit time without reversing the central opioid effect as measured by pupillometry. ... of morphine-induced pupil constriction, a central nervous system (CNS) effect. Escalating single ... while maintaining substantial central analgesic effect. In addition, ...
... Schedule Monday, September 17, 7:00 p.m. central Daylight Time, Room E354A -- Satellite ... Management Tuesday, September 18, 11:15 a.m. central Daylight Time, Room E253D Poster Session 222: ... Macaques Wednesday, September 19, 12:15 p.m. central Daylight Time, Hall D Poster Session 176: ...
... NTDDS projects are focused upon peripheral and central nervous system applications. To that end, ... ways using the synapse between the peripheral and central nervous systems. This synapse provides input from ... role not only in diabetes but also in several central nervous system-related diseases. Diamyd Medical ...
... (MS) is a chronic, progressive, often disabling disease that attacks the central nervous system(ii). MS is caused by damage to myelin, the protective sheath surrounding nerve fibers in the central nervous system, resulting in disrupted nerve impulses traveling to and ...
... platform technology to identify novel pathways for the treatment of central nervous system (CNS) diseases, announced today results from the first ... identify novel pathways for small molecule therapeutics to treat various central nervous system (CNS) diseases. Neurogenesis is the process by which ...
... to bringing the most complete and innovative cancer care to patients in central Wisconsin, which is why we are so excited to introduce electronic ... in Madison, WI. In November 2006 the Riverview center became the first in central Wisconsin to treat patients with helical tomotherapy, the most ...
... those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's ... media.relations@novartis.com Novartis Investor Relations central phone: +41 61 324 7944 Ruth Metzler-Arnold +41 61 324 9980 ...
... affects 0.5% - 5% of adults worldwide. Fibromyalgia is believed to be a central nervous system condition, resulting from neurological changes in how the ... development and commercialization of innovative medicines with a focus on central nervous system and immunology disorders. Employing around 10,000 people in ...
... developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced that it has obtained the rights to ... developing and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most advanced compound, a reversible inhibitor ...
... targets in peripheral tissues such as liver and fat without affecting the central nervous system, further validating Isis' anti-obesity therapeutic ... drugs could have significant therapeutic utility without the potential for central nervous system toxicities that plague many centrally acting anti-obesity ...
... AEs resulted from infections, liver enzyme increases and fully reversible central nervous system events. "The observation of high response rate and ... call will be available from 1:00 pm Eastern Time on June 8, 2009 (7:00 pm central European Time) through June 15, 2009. The replay number is 888-286-8010 ....
... the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial ... oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced ...
... announced that it has developed a robust medical imaging methodology for central Nervous System (CNS) clinical trials involving Alzheimer's disease. The ... and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and ...
... progression-free survival, which was assessed via a blinded independent, central radiological review(10). About Afinitor Afinitor is the first ... cancer cells, Afinitor continuously targets mTOR, a protein that acts as a central regulator of tumor cell division, blood vessel growth and cell metabolism. ...
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
... unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and ... the Benelux countries, and Poland for Eastern and central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. ...... the treatment of certain eye diseases, to include central Retinal Vein Occlusion (CRVO). The companies plan ... this year. CRVO is caused by obstruction of the central retinal vein that that leads to a back up of ... from CRVO. CRVO is caused by obstruction of the central retinal vein that leads to a back up of blood and ...
Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
... unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and ... the Benelux countries, and Poland for Eastern and central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. ...Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
... unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and ... the Benelux countries, and Poland for Eastern and central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. ...... to help prevent infections related to the use of central line catheters. central venous catheters or central line catheters are tubes placed into a large vein ...
Early Switch from IV to Oral Meds Is Effective for Children with Acute Bone Infection
... use: increased risk of complications from using central catheters, such as infections or breaks in the ... has been to supply antibiotics through a central venous catheter over a four- to six-week period ... IV therapy had complications related to the central venous catheter." Zaoutis's study found wide ...... The most common adverse events were related to central venous access, such as catheterization and catheter removal, central line infection and pyrexia. The study was ... including countries in Asia and South and central America, where the product is approved based on ...
... focused on the treatment of obesity and other central nervous system-related disorders, today ... focused on the treatment of obesity and other central nervous system-related disorders. The Company's ... to act on a specific group of neurons in the central nervous system with the goal of achieving ...
... (PFS) assessed via a blinded, independent central review and defined as the amount of time between ... groups (2% vs. 0% of responders). However, in a central review among patients evaluable for best ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
... Food and Drug Administration (FDA) to treat other central nervous system disorders. Orexigen has developed ... product candidates for the treatment of central nervous system disorders, including obesity. The ... other proprietary drugs for use in other central nervous system disorders. Further information ...... by continuously inhibiting the mTOR protein, a central regulator of tumor cell division and blood vessel ... RAD001 inhibits mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk
... kidney disease. SphygmoCor(R) is a non-invasive central blood pressure assessment technology that has ... in the "high normal" range (130-139 mm Hg) had central systolic blood pressures corresponding to those ... "The real significance of these findings is that central and brachial blood pressures are not the same, ...BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
... in South Africa as the key provider of global central lab services for clinical trials." Rudi Marien, ... + 329 329 2 327 BARC is an independent global central laboratory, with subsidiaries in USA, Europe, ... clinical trials. BARC is committed to providing central laboratory services, including biobanking, that ...... (PFS) assessed via a blinded, independent central review and defined as the amount of time between ... groups (1% vs. 0% of responders). However, in a central review among patients evaluable for ... RAD001 inhibits mTOR, a protein that acts as a central regulator of tumor cell division, ...
... Hospital, a major healthcare facility in West central Minnesota, today announced results from a ... range from complete automation systems for the central pharmacy to nursing unit and bedside dispensing ... facility that encompasses 14 counties in west central Minnesota and is licensed for 136 beds to provide ...
... reaches the brain and S1P-Rs are present on central nervous system (CNS) tissue, so FTY720 may have a ... metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ... 8425 Isabella Zinck +41 61 324 7188 central phone no: +41 61 324 7944 Fax no: ...
... disease) breathe more easily. central DuPage Hospital is the only site for the EASE ... and principal investigator of the study at the central DuPage Hospital site. "Emphysema, ... visit http://www.theEASEtrial.com . About central DuPage Hospital ...
... to expand our pipeline of product candidates in central nervous system disorders," said Paul E. Freiman, ... Technologies and Buck focused on central nervous system conditions. "With these ... on developing novel, first-in-class agents for central nervous system conditions and other serious ...
... treatment by inhibiting the mTOR protein, a central regulator of tumor cell division and blood vessel ... inhibits mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism ... metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal ...
Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
... experienced improvement in visual acuity and central macular thickness (CMT) as measured by optical coherence tomography. central macular thickness decreased in 55% of eyes and remained stable in 24%. An increase in central macular thickness was observed in only 20% of ...... cord that often leads to stroke or death. Primary central nervous system vasculitis (PCNSV) can best be ... a combined diagnostic approach is needed. Primary central nervous system vasculitis is difficult to ... of the Mayo Clinic Research Primary central nervous system vasculitis has two traits that ...
... disease is a progressive disorder of the central nervous system. The patients -- roughly four ... a lack of dopamine, a messenger substance in the central nervous system, which is responsible for the ... and biotechnology products in the fields of central nervous system disorders, ...
... (GI) transit time without reversing the central opioid effect as measured by pupillometry. ... of morphine-induced pupil constriction, a central nervous system (CNS) effect. Escalating single ... while maintaining substantial central analgesic effect. In addition, ...
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
... occurrence of scoliosis. In patients with GHD, central (secondary) hypothyroidism may first become ... treated with somatropin, previously undiagnosed central (secondary) hypoadrenalism may be ... fluid retention and unmasking of latent central hypothyroidism. Most serious adverse reactions ...Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
... occurrence of scoliosis. In patients with GHD, central (secondary) hypothyroidism may first become ... treated with somatropin, previously undiagnosed central (secondary) hypoadrenalism may be ... fluid retention and unmasking of latent central hypothyroidism. Most serious adverse reactions ...... Schedule Monday, September 17, 7:00 p.m. central Daylight Time, Room E354A -- Satellite ... Management Tuesday, September 18, 11:15 a.m. central Daylight Time, Room E253D Poster Session 222: ... Macaques Wednesday, September 19, 12:15 p.m. central Daylight Time, Hall D Poster Session 176: ...
... NTDDS projects are focused upon peripheral and central nervous system applications. To that end, ... ways using the synapse between the peripheral and central nervous systems. This synapse provides input from ... role not only in diabetes but also in several central nervous system-related diseases. Diamyd Medical ...
... (MS) is a chronic, progressive, often disabling disease that attacks the central nervous system(ii). MS is caused by damage to myelin, the protective sheath surrounding nerve fibers in the central nervous system, resulting in disrupted nerve impulses traveling to and ...
... platform technology to identify novel pathways for the treatment of central nervous system (CNS) diseases, announced today results from the first ... identify novel pathways for small molecule therapeutics to treat various central nervous system (CNS) diseases. Neurogenesis is the process by which ...
... to bringing the most complete and innovative cancer care to patients in central Wisconsin, which is why we are so excited to introduce electronic ... in Madison, WI. In November 2006 the Riverview center became the first in central Wisconsin to treat patients with helical tomotherapy, the most ...
... those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's ... media.relations@novartis.com Novartis Investor Relations central phone: +41 61 324 7944 Ruth Metzler-Arnold +41 61 324 9980 ...
... affects 0.5% - 5% of adults worldwide. Fibromyalgia is believed to be a central nervous system condition, resulting from neurological changes in how the ... development and commercialization of innovative medicines with a focus on central nervous system and immunology disorders. Employing around 10,000 people in ...
... developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced that it has obtained the rights to ... developing and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most advanced compound, a reversible inhibitor ...
... targets in peripheral tissues such as liver and fat without affecting the central nervous system, further validating Isis' anti-obesity therapeutic ... drugs could have significant therapeutic utility without the potential for central nervous system toxicities that plague many centrally acting anti-obesity ...
... AEs resulted from infections, liver enzyme increases and fully reversible central nervous system events. "The observation of high response rate and ... call will be available from 1:00 pm Eastern Time on June 8, 2009 (7:00 pm central European Time) through June 15, 2009. The replay number is 888-286-8010 ....
... the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial ... oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced ...
... announced that it has developed a robust medical imaging methodology for central Nervous System (CNS) clinical trials involving Alzheimer's disease. The ... and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and ...
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
... the delivery of diagnostic and therapeutic agents across the BBB into the central nervous system ("CNS"). The claims broadly encompass all neurological ... diagnostic and therapeutic agents across the blood-brain barrier into the central nervous system; that the allowed claims and patents, if issued, offer ...... progression-free survival, which was assessed via a blinded independent, central radiological review(10). About Afinitor Afinitor is the first ... cancer cells, Afinitor continuously targets mTOR, a protein that acts as a central regulator of tumor cell division, blood vessel growth and cell metabolism. ...
Other ContentsOther TagsOther Tags
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/21/2013)... Durham, NC Biologists have known for a long ... Exactly why isn,t well understood, particularly for plants. But ... Robert Lanfear of Australian National University and the U. ... study to be published 21 May in the journal ... shorter plants have faster-changing genomes. , Drawing from a ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2Drugs found to both prevent and treat Alzheimer's disease in mice 2(Date:5/23/2013)... Myers, FL (PRWEB) May 23, 2013 On ... prediction in the midst of growing numbers of H7N9 cases ... UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in Northern ... May 13th no new cases have been reported. , ... the flu is as predictable as flowers budding in the ...
(Date:5/23/2013)... 23 (HealthDay News) -- Schools should ensure that ... activity each day to support their health and ... report. Although previous studies show 60 ... health and development, it,s estimated that only about ... this recommendation, according to the report from the ...
(Date:5/23/2013)... (HealthDay News) -- A shortage of a critical tuberculosis ... the United States to contain the spread of the ... drug, isoniazid (INH), was first used in 1951 and ... core of any first-line treatment for tuberculosis (TB). Patients ... according to the U.S. Centers for Disease Control and ...
(Date:5/23/2013)... 2013 Special Learning, Inc., a ... resources for the autism, Down syndrome and special ... its first global autism treatment center and Special ... This new world-class program is the first of ... practices to treat and deliver exceptional education outcomes ...
(Date:5/23/2013)... May 23, 2013 Applied PilotFish ... today that it has added support for the Direct ... the eiConsole for Healthcare. In addition to the product’s ... LLP, FTP, and Web Services, it now offers support ... Protocol is a specification of the Direct Project ...
Breaking Medicine News(10 mins):Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2[0] UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine[0] U.S. School Kids Should Get Hour of Exercise Daily: Report[0] Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report[0] Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines[0] PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |